BRPI0914244A2 - Enzima com atividade contra clostridium - Google Patents

Enzima com atividade contra clostridium

Info

Publication number
BRPI0914244A2
BRPI0914244A2 BRPI0914244A BRPI0914244A BRPI0914244A2 BR PI0914244 A2 BRPI0914244 A2 BR PI0914244A2 BR PI0914244 A BRPI0914244 A BR PI0914244A BR PI0914244 A BRPI0914244 A BR PI0914244A BR PI0914244 A2 BRPI0914244 A2 BR PI0914244A2
Authority
BR
Brazil
Prior art keywords
enzyme
activity against
against clostridium
relates
present
Prior art date
Application number
BRPI0914244A
Other languages
English (en)
Inventor
Loessner Martin
Eichenseher Fritz
Original Assignee
Hyglos Invest Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyglos Invest Gmbh filed Critical Hyglos Invest Gmbh
Publication of BRPI0914244A2 publication Critical patent/BRPI0914244A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

ENZIMA COM ATIVIDADE CONTRA CLOSTRIDIUM. A presente invenção refere-se a um polipeptídeo possuindo a sequência de aminoácidos como mostrado na SEQ ID NO: 1, uma variante ou um fragmento da mesma. A presente invenção também refere-se a ácidos nucléicos que codificam os referidos polipeptídeos. A presente invenção também se refere ao uso dos polipeptídeos ou seus fragmentos como uma substância terapêutica ou diagnóstica bem como para a contaminação dos alimentos e alimentos.
BRPI0914244A 2008-07-07 2009-07-07 Enzima com atividade contra clostridium BRPI0914244A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08012261A EP2143729A1 (en) 2008-07-07 2008-07-07 New enzymatic active enzyme against Clostridium
PCT/EP2009/058579 WO2010003943A1 (en) 2008-07-07 2009-07-07 New enzymatic active enzyme against clostridium

Publications (1)

Publication Number Publication Date
BRPI0914244A2 true BRPI0914244A2 (pt) 2017-08-08

Family

ID=39737176

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0914244A BRPI0914244A2 (pt) 2008-07-07 2009-07-07 Enzima com atividade contra clostridium

Country Status (7)

Country Link
EP (1) EP2143729A1 (pt)
JP (1) JP2011527188A (pt)
CN (1) CN102076708A (pt)
AU (1) AU2009268084A1 (pt)
BR (1) BRPI0914244A2 (pt)
CA (1) CA2729317A1 (pt)
WO (1) WO2010003943A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102533929A (zh) * 2011-11-28 2012-07-04 中国食品发酵工业研究院 一种啤酒严格厌氧菌检测专用培养基
GB201302042D0 (en) * 2013-02-05 2013-03-20 Plant Bioscience Ltd Novel polypeptides having endolysin activity and uses thereof
KR101381797B1 (ko) * 2013-02-27 2014-04-07 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
KR101381798B1 (ko) 2013-02-27 2014-04-07 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
EP3372091A1 (en) * 2017-03-07 2018-09-12 Nomad Bioscience GmbH Method of reducing contamination of an object with clostridium
WO2019051179A1 (en) * 2017-09-08 2019-03-14 Regents Of The University Of Minnesota VECTORS, GENETICALLY MODIFIED BACTERIA, AND METHODS OF MAKING AND USING SAME
WO2025093666A1 (en) 2023-11-01 2025-05-08 University Of Copenhagen Treatment of lymphoma
WO2026052743A1 (en) 2024-09-04 2026-03-12 Micreos Human Health B.V. Reduction of trans-epidermal water loss by a polypeptide with antibacterial properties

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2253859A (en) * 1991-02-28 1992-09-23 Microbial Dev Ltd Use of bacteriophages to prevent microbial infestation
GB2255561B (en) * 1991-04-20 1995-06-21 Agricultural & Food Res Lysins from bacteriophages
DE4114646C2 (de) 1991-05-04 1996-02-29 Zeiss Carl Fa Ophthalmoskopie-Vorsatz für ein Operationsmikroskop
DE59510532D1 (de) * 1994-09-09 2003-02-20 Biotec Lab Ltd Aufschluss von bakterienzellen durch phagenlysine
GB0202556D0 (en) 2002-02-04 2002-03-20 Danisco Novel Protein

Also Published As

Publication number Publication date
JP2011527188A (ja) 2011-10-27
CN102076708A (zh) 2011-05-25
AU2009268084A1 (en) 2010-01-14
CA2729317A1 (en) 2010-01-14
WO2010003943A1 (en) 2010-01-14
EP2143729A1 (en) 2010-01-13

Similar Documents

Publication Publication Date Title
BRPI0914244A2 (pt) Enzima com atividade contra clostridium
BR112012006501A8 (pt) Polipeptídios e usos dos mesmos
BR112013010844A2 (pt) nova endolisina
BR112012033404A2 (pt) polipetídeo tendo ou auxiliando a atividade de degradação de material de carboidratos e uso dos mesmos.
BR112015012152A2 (pt) Proteína de fusão terapêutica direcionada que compreende uma enzima lisossomal, ácido nucleico, composição farmacêutica, método para produzir a dita proteína e usos da proteína para tratar uma doença de armazenamento lisossomal e mucopolissacaridose tipo iiib
BRPI0516455A (pt) fitase de citrobacter freundii e homólogos
MX2012002216A (es) Nueva endolisina obpgplys.
BR112012029588A2 (pt) materiais biológicas relacionados a her3.
CY1122128T1 (el) Θεραπεια ενζυμικης αντικαταστασης με κλιμακωση δοσης για αντιμετωπιση ανεπαρκειας σε οξινη σφιγγομυελιναση
BRPI1015536A2 (pt) polipeptídeo de degradação de carboidratos e usos do mesmo
BRPI1008740A8 (pt) Proteínas pesticidas e métodos para seu uso.
BRPI0814097A8 (pt) Derivado do peptídeo insulinotrópico cm seu aminoácido n-terminal modificado
BR112014024282A2 (pt) anticorpos ligantes ao receptor b1 da bradicinina
BR112012033699A2 (pt) polipeptídeo tendo atividade beta-glicosidase e seus usos
BRPI0914684C1 (pt) uso de hsp70 ou um fragmento funcional ou variante do mesmo, e, hsp70 ou um fragmento funcional ou variante do mesmo
BR112012033703A2 (pt) polipeptídeo tendo atividade beta-glicosidase e seus usos
MX2009012650A (es) Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos.
BR112014001909A2 (pt) gene da toxina axmi270 e métodos para a sua utilização
BRPI0611535A8 (pt) Métodos para processar células de microorganismos e células de levedura, composição, suplemento alimentar, produto farmacêutico, cosmético ou produto nutracêutico e ração animal
MX340541B (es) Secuencias de aminoacidos mejoradas dirigidas contra virus sincitial respiratorio humano y polipeptidos que comprenden las mismas para la prevencion y/o tratamiento de infecciones del tracto respiratorio.
BRPI0609797B8 (pt) nanocorpos melhorados para o tratamento de desordens mediadas por agregação
BR112014001978A2 (pt) proteínas variantes axmi205 e métodos para a utilização das mesmas
BR112012019924A2 (pt) polipeptídeos de ligação de agonista de dr5.
WO2011036442A3 (en) Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders
BRPI0720879A2 (pt) microvesícula derivada de fermento carreador de fator de tecido (tf), composição e composição farmacêutica que a compreende, processos para a sua manufatura, proteína lipida de fator de tecido (tf) modificado, polinucleotídeo, vetor, célula hospedeira e anticorpo.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]